Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2013
04/25/2013US20130102778 Process for the preparation of isoxazolyl- methoxy nicotinic acids
04/25/2013US20130102777 PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2--ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID
04/25/2013US20130102775 Photochromic material
04/25/2013US20130102774 Thionation process and a thionating agent
04/25/2013US20130102623 Tricyclic Compounds Having Cytostatic and/or Cytotoxic Activity and Methods of Use Thereof
04/25/2013US20130102621 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same
04/25/2013US20130102620 Pyrazolopyrimidine derivative
04/25/2013US20130102613 Treatment of cancer with tor kinase inhibitors
04/25/2013US20130102599 Pyrazolo [4,3-c] cinnolin-3-one m1 receptor positive allosteric modulators
04/25/2013US20130102587 New Enzyme Inhibitor Compounds
04/25/2013US20130101622 Imidazoquinoxaline compounds as immunomodulators
04/25/2013DE102012004736A1 New 4-amino-3-phenylamino-6-phenylpyrazolo(3,4-d)pyrimidine derivatives useful as a medicament for prophylactic- or therapeutic treatment of viral infections, preferably picornavirus infections and rhinovirus infections
04/25/2013CA2852939A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
04/25/2013CA2852937A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
04/25/2013CA2852936A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
04/25/2013CA2852921A1 Treatment of cancer with tor kinase inhibitors
04/25/2013CA2852615A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators
04/25/2013CA2850440A1 Process for the preparation of isoxazolyl-methoxy-nicotinic acids
04/24/2013EP2583970A1 Certain chemical entities, compositions and methods comprising imidazopyrimidines
04/24/2013EP2582703A1 Heteroaryl imidazolone derivatives as jak inhibitors
04/24/2013EP2582702A1 Pyrazolopyrimidine kinase inhibitors
04/24/2013EP2582700A2 Respiratory formulations and compounds for use therein
04/24/2013EP2240454B1 Mesoionic pesticides
04/24/2013CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
04/24/2013CN1653050B Opioid and opioid-like compounds and uses thereof
04/24/2013CN103068828A Triazolopyrazine derivatives
04/24/2013CN103068827A Fused heterocyclic derivatives as s1p modulators
04/24/2013CN103059052A Rare-earth metal compound and synthetic process thereof
04/24/2013CN103059042A Thiophene derivative and application thereof to medicine
04/24/2013CN103059033A New method for preparing formyl-porphyrins
04/24/2013CN103059032A Separation technology of cyclic dipeptide C3 contained in phellinus igniarius
04/24/2013CN103059031A High-pressure reverse-phase preparation separation technology of cyclic dipeptide C7 contained in phellinus igniarius
04/24/2013CN103059030A Pyrimidine compound with effect of adhesion kinase inhibition and preparation method and application thereof
04/24/2013CN103059029A Hexahydro-pyrrole[2,3]indole compound and its preparation method and use in bactericidal activity
04/24/2013CN103058891A Method for producing biruea and urotropine
04/24/2013CN102153559B Novel method for synthesizing sitagliptin phosphate and derivative thereof
04/24/2013CN101945875B Azaindolizines and methods of use
04/24/2013CN101809021B Octahydro-pyrrolo[3,4-b]pyrrole N-oxides
04/24/2013CN101720325B Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
04/24/2013CN101611036B Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
04/24/2013CN101605793B Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
04/24/2013CN101558071B Substituted quinazolines
04/24/2013CN101535312B 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors
04/24/2013CN101326188B Pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2A]pyrazin-1-one compounds
04/24/2013CN101305006B Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
04/23/2013US8426610 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino[4,5-c]pyrrole
04/23/2013US8426588 Phenylalanine derivatives
04/23/2013US8426583 Processes for preparing certain hexaazaisowurtzitanes and their use in preparing hexanitrohexaazaisowurtzitane
04/23/2013US8426437 Pyrroloquinoline derivatives and their use as protein kinases inhibitors
04/23/2013US8426428 EGFR kinase knockdown via electrophilically enhanced inhibitors
04/23/2013CA2709202C Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
04/23/2013CA2623047C 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5 amine
04/23/2013CA2610042C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
04/23/2013CA2549954C Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics
04/23/2013CA2436245C Medicament for protection in radiotherapy
04/18/2013WO2013056060A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/18/2013WO2013056015A1 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
04/18/2013WO2013055987A1 Pyrrolobenzodiazepines and conjugates thereof
04/18/2013WO2013055984A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/18/2013WO2013055897A1 8 - carbamoyl - 2 - (2,3- di substituted pyrid - 6 - yl) -1,2,3,4 -tetrahydroisoquinoline derivatives as apoptosis - inducing agents for the treatment of cancer and immune and autoimmune diseases
04/18/2013WO2013055747A1 Methods to produce alkylated polycyclic guanidine compounds
04/18/2013WO2013055645A1 5,7-substituted-imidazo[1,2-c]pyrimidines
04/18/2013WO2013054291A1 Novel oxazine derivatives and their use in the treatment of disease
04/18/2013WO2013054185A1 Pyrimidine and pyridine derivatives useful in therapy
04/18/2013WO2013053942A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances
04/18/2013WO2013053873A1 Pyrrolobenzodiazepines
04/18/2013WO2013053872A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
04/18/2013WO2013053871A1 Pyrrolobenzodiazepines
04/18/2013WO2013053690A1 Pde9i with imidazo pyrazinone backbone
04/18/2013WO2013053657A1 Antiviral compounds
04/18/2013WO2013053202A1 Pyrrolo pyrroledione-thenequinone compound, and preparation process and use thereof
04/18/2013WO2013053045A1 Heterocyclic molecules as apoptosis inducers
04/18/2013US20130096316 Novel Method for Preparation of Bisnorcymerine and Salts Thereof
04/18/2013US20130096315 Certain chemical entities, compositions and methods
04/18/2013US20130096302 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
04/18/2013US20130096146 Tricyclic Compounds Having Antimitotic and/or Antitumor Activity and Methods of Use Thereof
04/18/2013US20130096144 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
04/18/2013US20130096129 Activators of class i histone deacetlyases (hdacs) and uses thereof
04/18/2013US20130096128 Pyrazole compounds useful as protein kinase inhibitors
04/18/2013US20130096118 Carboline carboxamide compounds useful as kinase inhibitors
04/18/2013US20130096114 Pharmacokinetically improved compounds
04/18/2013US20130096113 Heterocyclic compounds and methods of use thereof
04/18/2013US20130096110 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction
04/18/2013US20130096109 Pyridone derivative having integrase inhibitory activity
04/18/2013US20130095066 Compounds for the Treatment of Hepatitis C
04/18/2013US20130095035 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
04/18/2013DE102011116373A1 Preparing substituted amino-phenylamino-phenyl-pyrazolo(3,4-d)pyrimidine derivatives useful e.g. for treating picornavirus infection, comprises reacting substituted amino-phenylamino-pyrazole-carbonitrile compounds and benzamidine compounds
04/18/2013DE102011054477A1 Verfahren zur katalytischen Heteroaromatenhydrierung Process for the catalytic Heteroaromatenhydrierung
04/18/2013CA2851810A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/18/2013CA2851623A1 5,7-substituted-imidazo[1,2-c]pyrimidines
04/18/2013CA2851445A1 Novel oxazine derivatives and their use in the treatment of disease
04/18/2013CA2851364A1 8-carbamoyl-2-(2,3-di substituted pyrid-6-yl)-1,2,3,4-tetrahydroisoquinoline derivatives as apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
04/18/2013CA2851155A1 Heterocyclic compounds and methods of use thereof
04/18/2013CA2850439A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents
04/18/2013CA2850264A1 Pyrrolobenzodiazepines
04/18/2013CA2850103A1 Pyrrolobenzodiazepines
04/18/2013CA2850096A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
04/18/2013CA2847083A1 Antiviral compounds
04/17/2013CN103052639A 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
04/17/2013CN103052638A Process for the preparation of dimiracetam
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 573